Captrust Financial Advisors Increase Stock Position in Baxter International to $5.05 Million

Trending News ☀️

Baxter International Intrinsic Value – Baxter International ($NYSE:BAX) Inc. is a global healthcare company that provides life-saving therapies to patients around the world. The company is headquartered in Deerfield, Illinois, and its stock is traded on the New York Stock Exchange (NYSE:BAX). Recently, Captrust Financial Advisors, one of the leading financial advisors in the United States, has increased its stock position in Baxter International Inc. to $5.05 million. Firstly, the company has been able to capitalize on the growing demand for its products and services, particularly in the United States, where it is one of the leading players in the healthcare sector.

Additionally, the company has made a number of strategic acquisitions over the past few years, which have helped to expand its portfolio and increase its market share. Finally, Baxter International Inc. has also been successful in capitalizing on the growing trend towards personalized medicine and healthcare solutions, which has helped to drive growth in its sales and profits. With a strong market position and a healthy balance sheet, the company is well-positioned to capitalize on future growth opportunities. Additionally, with a stock position of $5.05 million held by Captrust Financial Advisors, investors can be confident that the company has strong support from an experienced financial advisor.

Stock Price

Despite the current news sentiment being mostly negative, Baxter International Inc.’s stock opened at $49.0 on Monday and closed at $50.0, representing a 0.5% increase from its last closing price of 49.7. The company has a long history of providing high-quality products and services to its customers, and its financial performance has consistently been strong. Baxter International Inc. is an attractive investment for investors who are looking for long-term value. The company has a strong balance sheet and has a history of increasing dividends for its shareholders.

Additionally, the company has a track record of successfully adapting to changes in the healthcare industry and has been able to maintain its competitive advantage in the market. Given Baxter International Inc.’s history of strong financial performance and its ability to adjust quickly to changing market conditions, Captrust Financial Advisors’ decision to increase their stock position in the company is understandable. Investors looking for long-term value should consider investing in Baxter International Inc., as it has a proven track record of success and is well-positioned to continue benefiting investors in the future. Live Quote…

About the Company

Key Ratios Snapshot

Some of the financial key ratios for Baxter International are shown below. More…

VI Analysis – Baxter International Intrinsic Value Calculator

Baxter International is a diversified healthcare company with a long-term potential reflected in its fundamentals. The VI app simplifies analysis of the company to provide a fair value of its shares, which is currently around $91.9. Based on this valuation, the stock is currently trading at $50.0, representing an undervaluation of approximately 46%. The company is focused on providing healthcare products and services to patients and healthcare professionals worldwide. Its portfolio includes medical products, pharmaceuticals, and biotechnology solutions. The company’s products and services are used in a variety of healthcare settings such as hospitals, dialysis centers, nursing homes, and pharmacies. Additionally, Baxter’s products and services are used in the home setting for self-care. Baxter’s strong financial performance has been driven by its commitment to innovation, operational excellence, and strategic investments. In addition, the company has consistently been able to generate strong cash flow from operating activities and has been able to return value to shareholders through dividend payments and share repurchases. Overall, Baxter International is a solid long-term investment opportunity due to its strong fundamentals. Its current price provides investors with an attractive entry point as the stock is trading at a discount compared to its fair value. More…

VI Peers

Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.

– Utah Medical Products Inc ($NASDAQ:UTMD)

The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.

– Clarity Medical Group Holding Ltd ($SEHK:01406)

According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.

– Merit Medical Systems Inc ($NASDAQ:MMSI)

Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.

Summary

Investing in Baxter International Inc. can be an attractive option for many investors. This healthcare company provides a range of products and services, such as biopharmaceuticals, specialty injectable drugs, and intravenous solutions and nutrition products. As a result, Baxter offers investors a diversified portfolio of healthcare options with various levels of risk and reward. When considering whether to invest in Baxter International Inc., it is important to understand the risks associated with the company. Baxter is dependent on government regulations that affect the healthcare sector and its industry. The company also relies heavily on third-party suppliers and could be adversely affected if those suppliers fail to meet its needs. Additionally, Baxter’s financial performance could be affected by changes in the healthcare sector or in the industry as a whole. Despite these risks, many investors still find Baxter International Inc. an attractive option. The company has demonstrated strong growth in recent years and its products and services are well-regarded in the medical industry. Baxter is also a large and well-established company, which can provide stability and long-term investment potential. Additionally, Baxter has a strong track record of dividend payments and could be a good option for investors who want to generate income from their investments. In conclusion, Baxter International Inc. may be an attractive option for investors who are looking for potential growth and income from their investments.

However, it is important for investors to understand the risks associated with the company before making any decisions.

Additionally, investors should keep up to date with news and developments related to Baxter and the healthcare industry in order to stay informed about any changes that may affect their investment decisions.